Reducing PD-L1 expression with a self-assembled nanodrug: an alternative to PD-L1 antibody for enhanced chemo-immunotherapy

The binding between the immune checkpoints, programmed cell death ligand 1 (PD-L1) and programmed cell death 1 (PD-1), compromises T-cell-mediated immune surveillance. Immune checkpoint therapy using immune checkpoint inhibitors (ICIs) to block PD-L1 on cancer cell membrane or PD-1 on activated T ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Shuxian, Chen, Ziyi, Wang, Yingjie, Wang, Min, Wu, Junye, Tong, Yuhong, Chen, Lanlan, Lu, Chunhua, Yang, Huanghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778587/
https://www.ncbi.nlm.nih.gov/pubmed/33408792
http://dx.doi.org/10.7150/thno.45777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778587/
https://www.ncbi.nlm.nih.gov/pubmed/33408792
http://dx.doi.org/10.7150/thno.45777

Ejemplares similares